Skip to content
OpenCapital
Get started

Sutro Biopharma STRO Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Regenxbio logo
RegenxbioRGNX
$432.52M+20.8%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$204.78M-10.4%
Xencor logo
XencorXNCR
$884.46M+18.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.59B+180%

Other financials

Income statement

See full
Revenue$14.5M-16.5%
Operating income-$29.7M+56.7%
Net income-$38.5M+49.3%
EPS (diluted)-$2.94+67.6%

Balance sheet

See full
Cash & equivalents$73.7M-30.6%
Total debt$13.6M-36.3%
Total equity-$66.9M-159%
Total assets$242.0M-24.7%

Cash flow

See full
Operating cash flow-$42.3M+37.7%
CapEx--100%
Free cash flow-$42.3M+37.8%

Valuation

See full
Enterprise value$429.61M-2,600%
P/S4.9×+3.9×

Profitability

See full
Operating margin-120%-48.6pp
Net margin-154.2%-56.7pp
FCF margin-152.2%-51.1pp

Returns & leverage

See full
Return on equity-234.2%—
Debt / equity0.5×+0.3×
Current ratio3.1×+1.0×

Where this comes from

Computed from the period-end share price: $412.69M.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sutro Biopharma's market capitalization?
Sutro Biopharma (STRO) reported market capitalization of $412.69M in Q1 2026.
How has Sutro Biopharma's market capitalization changed year-over-year?
Sutro Biopharma's market capitalization increased by 657.2% year-over-year, from $54.5M to $412.69M.
What is the long-term trend for Sutro Biopharma's market capitalization?
Over 5 years (2020 to 2025), Sutro Biopharma's market capitalization has grown at a -37.1% compound annual growth rate (CAGR), from $1B to $98.57M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.